CN Patent

CN101299992A — 药物活性物质长效输送用羧烷基纤维素酯

Assigned to Eastman Chemical Co · Expires 2008-11-05 · 18y expired

What this patent protects

本文中公开的是包含药物活性物质长效输送用羧烷基纤维素酯的医药组合物。该组合物包含至少一种医药活性剂和至少一种包含有结构(I)的葡糖酐重复单元的羧烷基纤维素酯,式中R 1 ~R 6 各自独立地选自-OH、-OC(O)(烷基)、和-O(CH 2 ) x C(O)OH,及其医药上可接受盐,式中x的范围为1~3,每个葡糖酐的OH取代度范围为0.1~0.7,每个葡糖酐的-C(O)(烷基)取代度范围为0.1~2.7,且每个葡糖酐的-O(CH 2 ) x C(O)OH取代度范围为0.2~0.75,且其中在医药上可接受介质中该组合物显示出该至少一种药物活性剂的长效释放。…

USPTO Abstract

本文中公开的是包含药物活性物质长效输送用羧烷基纤维素酯的医药组合物。该组合物包含至少一种医药活性剂和至少一种包含有结构(I)的葡糖酐重复单元的羧烷基纤维素酯,式中R 1 ~R 6 各自独立地选自-OH、-OC(O)(烷基)、和-O(CH 2 ) x C(O)OH,及其医药上可接受盐,式中x的范围为1~3,每个葡糖酐的OH取代度范围为0.1~0.7,每个葡糖酐的-C(O)(烷基)取代度范围为0.1~2.7,且每个葡糖酐的-O(CH 2 ) x C(O)OH取代度范围为0.2~0.75,且其中在医药上可接受介质中该组合物显示出该至少一种药物活性剂的长效释放。也公开的是长效输送例如服从零级动力学的输送用组合物的给药方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101299992A
Jurisdiction
CN
Classification
Expires
2008-11-05
Drug substance claim
No
Drug product claim
No
Assignee
Eastman Chemical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.